@prefix cas: <http://identifiers.org/cas/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix inchikey: <http://identifiers.org/inchikey/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-Keio_Univ-KO002238 a mbo:MassSpectrum ;
    dcterms:creator "Kakazu Y, Horai H, Institute for Advanced Biosciences, Keio Univ." ;
    dcterms:date "2016-01-19 (Created 2007-07-07, modified 2011-05-10)"^^xsd:date ;
    dcterms:identifier "MSBNK-Keio_Univ-KO002238" ;
    dcterms:license <https://creativecommons.org/licenses/by/4.0/> ;
    dcterms:rights " under CC BY-NC-SA" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "API3000, Applied Biosystems" ;
            mbo:collision_energy "10 V" ;
            mbo:instrument_type "LC-ESI-QQ" ;
            mbo:ion_mode "POSITIVE" ;
            mbo:ms_type "MS2" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            rdfs:label "Apramycin",
                "Apramycin sulfate" ;
            mbo:ch_compound_class "N/A" ;
            mbo:ch_exact_mass 5.392803e+02 ;
            rdfs:seeAlso cas:37321-09-8,
                <http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CIDSID:4713> ;
            schema:inChI "InChI=1S/C21H41N5O11/c1-26-11-14(30)18-8(33-20(11)37-21-16(32)13(29)10(25)9(4-27)34-21)3-7(24)19(36-18)35-17-6(23)2-5(22)12(28)15(17)31/h5-21,26-32H,2-4,22-25H2,1H3/t5-,6+,7-,8-,9-,10-,11+,12+,13+,14-,15-,16-,17-,18+,19+,20+,21-/m1/s1" ;
            schema:inChIKey inchikey:XZNUGFQTQHRASN-UXNWEDNLSA-N ;
            schema:molecularFormula "C21H41N5O11" ;
            schema:name "Apramycin",
                "Apramycin sulfate" ;
            schema:smiles "OC[C@@H](O1)[C@@H](N)[C@H](O)[C@@H](O)[C@H]1O[C@H](O2)[C@@H](NC)[C@@H](O)[C@@H](O3)[C@@H](C[C@@H](N)[C@@H](O[C@H]([C@@H](N)4)[C@H](O)[C@@H](O)[C@H](N)C4)3)2" ] ;
    mbo:has_peak [ mbo:intensity 1.18812e+05 ;
            mbo:mz 1.704e+02 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 9 ],
        [ mbo:intensity 2.47525e+04 ;
            mbo:mz 2.422e+02 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 2 ],
        [ mbo:intensity 3.46535e+04 ;
            mbo:mz 2.606e+02 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 3 ],
        [ mbo:intensity 3.46535e+04 ;
            mbo:mz 3.623e+02 ;
            mbo:peak_sequential_number 4 ;
            mbo:relative_intensity 3 ],
        [ mbo:intensity 7.42575e+04 ;
            mbo:mz 3.781e+02 ;
            mbo:peak_sequential_number 5 ;
            mbo:relative_intensity 5 ],
        [ mbo:intensity 2.9703e+04 ;
            mbo:mz 3.886e+02 ;
            mbo:peak_sequential_number 6 ;
            mbo:relative_intensity 2 ],
        [ mbo:intensity 4.9505e+04 ;
            mbo:mz 4.342e+02 ;
            mbo:peak_sequential_number 7 ;
            mbo:relative_intensity 4 ],
        [ mbo:intensity 3.46535e+04 ;
            mbo:mz 5.237e+02 ;
            mbo:peak_sequential_number 8 ;
            mbo:relative_intensity 3 ],
        [ mbo:intensity 1.368813e+07 ;
            mbo:mz 5.406e+02 ;
            mbo:peak_sequential_number 9 ;
            mbo:relative_intensity 999 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:precursor_mz 5.4e+02 ;
            mbo:precursor_type mbo:IT003 ] ;
    mbo:pk_num_peak 9 ;
    mbo:pk_splash "splash10-0006-0000090000-ea507c032d1b172012e3" ;
    rdfs:comment "KEIO_ID A100" ;
    skos:definition "Apramycin; LC-ESI-QQ; MS2; CE:10 V; [M+H]+" .

